Hemant Surgical Industries P/B Ratio
HSIL • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
3.34
High Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
3.34
Current Price
₹
Book Value/Share
₹63.00
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹63 Cr
Share Capital
₹10 Cr
Reserves & Surplus
₹53 Cr
Outstanding Shares
10,000,000
Book Value per Share
₹63.00
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
-0.15
Sector Median
0.64
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Hemant Surgical Industries
- Stock appears overvalued with PB of 3.34, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.15
View the current stock price of Hemant Surgical Industries for more insights.
Related Pages for Hemant Surgical Industries
Additional stock information and data for HSIL
Sector P/B Ratio Comparison
Comparing Hemant Surgical Industries with other companies in Healthcare sector
Sector Average
-0.15
Sector Median
0.64
Lowest P/B
-12.06
Highest P/B
1.1
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.06 | ₹4,124 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |